Jump to content

Category:David NETT of Danville CA (US)

From WikiTrademarks

David NETT of Danville CA (US)

Executive Summary

David NETT of Danville CA (US) is an inventor who has filed 1 patents. Their primary areas of innovation include X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy ( (1 patents), X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy ( (1 patents), X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy ( (1 patents), and they have worked with companies such as RefleXion Medical, Inc. (1 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

File:David NETT of Danville CA (US) Monthly Patent Applications.png

Technology Areas

File:David NETT of Danville CA (US) Top Technology Areas.png

List of Technology Areas

  • A61N5/1081 (X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy (): 1 patents
  • A61N5/1045 (X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy (): 1 patents
  • A61N5/1049 (X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy (): 1 patents
  • A61N2005/005 (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents): 1 patents
  • A61N2005/1052 (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents): 1 patents
  • A61N2005/1091 (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents): 1 patents
  • A61N2005/1094 (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents): 1 patents
  • G21K1/046 ({varying the contour of the field, e.g. multileaf collimators}): 1 patents

Companies

File:David NETT of Danville CA (US) Top Companies.png

List of Companies

  • RefleXion Medical, Inc.: 1 patents

Collaborators

Subcategories

This category has the following 10 subcategories, out of 10 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.